Tags: Vivreon Biosciences

announcements

Vivreon Biosciences Awarded Grant to Advance Drug Program Targeting Neuroinflammation

Vivreon Biosciences, LLC has been awarded a preclinical drug discovery grant from the Alzheimer's Drug Discovery Foundation (ADDF) to develop compounds that targets brain inflammation in Alzheimer's disease.